Novo Nordisk's US headquarters under fire in latest FDA warning letter
10th March 2026 Uncategorised 0Amid the company’s efforts to resolve issues raised during an FDA inspection early last year, Novo Nordisk’s operating base in Plainsboro, New Jersey—already the recipient of a recent Form 483—has been hit with the more severe consequence of a warning letter.
More: Novo Nordisk's US headquarters under fire in latest FDA warning letter
Source: fierce